Prostate Cancer Pathology: Recent Updates and Controversies
- PMID: 30228708
- PMCID: PMC6139855
Prostate Cancer Pathology: Recent Updates and Controversies
Abstract
Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.
Figures
References
-
- Epstein JI, Egvad L, Amin MB, Delahunt B, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244–252. - PubMed
-
- Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. 4th ed. IARC; Lyon, France: 2016. - PubMed
-
- Srigley JR, Delahunt B, Evans AJ. Therapy-associated effects in the prostate gland. Histopathology. 2012;60:153–165. - PubMed
-
- Srigley JR, Zhou M, Amin MB, et al. College of American Pathologists protocol for the examination of specimens from patients with carcinoma of the prostate gland. [Accessed: 6/14/2017]. Version: Prostate 3.3.0.0, revised February 28, 2017 www.cap.org/cancerprotocols.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials